Mefenamic acid inhibit transforming growth factor-beta type-1: Repurposing anti-inflammatory drugs in wound healing using in-silico approaches

QR Code

Mefenamic acid inhibit transforming growth factor-beta type-1: Repurposing anti-inflammatory drugs in wound healing using in-silico approaches

Due to low cost and time-saving benefits, drug repurposing is a safe and successful method to discover drug. A druggable target for inflammation, transforming growth factor-beta type-1 (TGF-β 1) has been identified to be associated with wound healing. Finding the most effective TGF-β 1 inhibitor amo...

Full description

Bibliographic Details
Main Authors:	Roney, Miah, Issahaku, Abdul Rashid, Normaiza, Zamri, Mohd Fadhlizil Fasihi, Mohd Aluwi
Format:	Article
Language:	English
Published:	Elsevier B.V. 2023
Subjects:	HD Industries. Land use. Labor R Medicine (General)
Online Access:	http://umpir.ump.edu.my/id/eprint/41783/ http://umpir.ump.edu.my/id/eprint/41783/1/Mefenamic%20acid%20inhibit%20transforming%20growth%20factor-beta%20type-1%20-%20Repurposing%20anti-inflammatory%20drugs%20in%20wound%20healing%20using%20in-silico%20approaches.pdf

Similar Items

An in-silico approach to evaluate bioactive molecules of aloe vera leaf extracts in inhibiting the glycogen synthase kinase-3β (GSK3-β) protein for faster diabetic wound healing potential
by: Roney, Miah, et al.
Published: (2024)

Diabetic wound healing of aloe vera major phytoconstituents through TGF-b1 suppression via in-silico docking, molecular dynamic simulation and pharmacokinetic studies
by: Roney, Miah, et al.
Published: (2023)

The importance of in-silico studies in drug discovery
by: Roney, Miah, et al.
Published: (2024)

Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer's disease using network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2025)

Inhibitory effect of Sinapic acid derivatives targeting structural and non-structural proteins of dengue virus serotype 2 An in-silico assessment
by: Roney, Miah, et al.
Published: (2023)

Design and in-silico studies of abacavir analogues as Anti-DENV-2 NS5 methyltransferase
by: Roney, Miah, et al.
Published: (2025)

Insights from in silico exploration of major curcumin analogs targeting human dipeptidyl peptidase IV
by: Roney, Miah, et al.
Published: (2024)

Computational screening of FDA-approved hepatitis c drugs for inhibition of VEGFR2 in liver cancer
by: Roney, Miah, et al.
Published: (2024)

In silico analysis for discovery of dengue virus inhibitor from natural compounds
by: Roney, Miah, et al.
Published: (2022)

Exploration of leads from bis-indole based triazine derivatives targeting human aldose reductase in diabetic type 2: In-silico approaches
by: Roney, Miah, et al.
Published: (2025)

Comprehending the pharmacological mechanism of marine phenolic acids in bladder cancer therapy against matrix metalloproteinase 9 protein by integrated network pharmacology and in-silico approaches
by: Roney, Miah, et al.
Published: (2024)

Virtual screening of pyrazole derivatives of usnic acid as new class of anti-hyperglycemic agents against PPARγ agonists
by: Roney, Miah, et al.
Published: (2023)

In-silico Studies of Usnic Acid against DENV-3 Methyltransferase
by: Roney, Miah, et al.
Published: (2023)

Cancer drug resistance is a serious threat in Bangladesh
by: Roney, Miah, et al.
Published: (2024)

Identification of potent new brain cancer EGFR inhibitor from usimine A and usimine B: computer-aided drug design perspective
by: Roney, Miah, et al.
Published: (2024)

Therapeutic potential inhibitor for dipeptidyl peptidase IV in diabetic type 2: In silico approaches
by: Roney, Miah, et al.
Published: (2025)

In silico exploration of Isoxazole derivatives of usnic acid: novel therapeutic prospects against α-Amylase for diabetes treatment
by: Roney, Miah, et al.
Published: (2024)

In silico evaluation of usnic acid derivatives to discover potential antibacterial drugs against DNA gyrase B and DNA topoisomerase IV
by: Miah, Roney, et al.
Published: (2023)

Drug repurposing of clinically-approved drugs to target epithelial-mesenchymal transition using in silico analysis
by: Ong, Chun Hao
Published: (2021)

Anti-inflammatory and wound healing properties of Malaysia tualang honey
by: Devasvaran, Kogilavanee, et al.
Published: (2016)

In-silico design of curcumin analogs as potential inhibitors of dengue virus NS2B/NS3 protease
by: Roney, Miah, et al.
Published: (2023)

Anti-diabetic activity of phloretin against maltase-glucoamylase using docking, pharmacokinetics and pharmacophore studies
by: Roney, Miah, et al.
Published: (2023)

Computational studies demonstrating dithymoquinone of Nigella sativa as a potential anti-dengue agent: Short review
by: Roney, Miah, et al.
Published: (2024)

Oropouche fever outbreak is emerging concern in American countries
by: Roney, Miah, et al.
Published: (2024)

Evolution of SARS-CoV-2 from BA.2.86 to JN.1 variations and detection in Bangladesh
by: Roney, Miah, et al.
Published: (2024)

Dengue death rate higher among women than men in Bangladesh
by: Roney, Miah, et al.
Published: (2024)

Deciphering the mechanism of usnic acid in type 2 diabetes treatment: A network pharmacology and molecular docking approach
by: Roney, Miah, et al.
Published: (2025)

Wound Healing Activity of Pyrazole-thiazole Derivatives of Curcumin Through the Docking, Pharmacokinetics, MD Simulation and MM/GBSA Approaches
by: Forid, Md Shaekh, et al.
Published: (2024)

Molecular docking and in silico evaluation of phytochemicals of bioactive methanolic extract of Ipomoea mauritiana Jacq. as anti-bacterial agents
by: Roney, Miah, et al.
Published: (2022)

In silico identification of PPARγ agonists from diffractaic acid analogs in prostate cancer: a comprehensive computational approach
by: Roney, Miah, et al.
Published: (2025)

Formation of encapsulated mefenamic acid-beta cyclodextrin and unencapsulated mefenamic acid using electrospray technique / Nurul Karimah Zolkepali
by: Zolkepali, Nurul Karimah
Published: (2016)

Curcumin, a bioactive compound of Turmeric (Curcuma longa) and its derivatives as α-amylase and α-glucosidase inhibitors
by: Roney, Miah, et al.
Published: (2024)

In vitro and in silico insights into the soybean 15-lipoxygenase inhibition with a new C-geranylated chalcone-based flavanone
by: Segaran, Raaginie Tamil, et al.
Published: (2025)

Phenolic compounds of Theobroma cacao L. show potential against dengue RdRp protease enzyme inhibition by In-silico docking, DFT study, MD simulation and MMGBSA calculation
by: Moyeenul Huq, A. K. M., et al.
Published: (2024)

Gelam Honey: a review of its antioxidant, anti-inflammatory, anticancer and wound healing aspects
by: Putri Shuhaili S,, et al.
Published: (2016)

Antioxidant and antibacterial activity of Ipomoea mauritiana Jacq.: a traditionally used medicinal plant in Bangladesh
by: Alam, Istiak, et al.
Published: (2020)

Discovery of COVID-19 protein inhibitors in phenolic acids of azadirachta indica (neem) using docking and pharmacokinetics
by: Roney, Miah, et al.
Published: (2024)

Identification of β-cycloidal-derived mono-carbonyl curcumin analogs as potential interleukin-6 inhibitor to treat wound healing through QSAR, molecular docking, MD simulation, MM-GBSA calculation
by: Forid, Md Shaekh, et al.
Published: (2024)

Pharmacophore-based virtual screening and in-silico study of natural products as potential DENV-2 RdRp inhibitors
by: Miah, Roney, et al.
Published: (2023)

A composition for wound healing
by: Mohamed, Suhaila, et al.
Published: (2008)